TickerFacts.

Cardiff Oncology, Inc. (CRDF): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2018-08-03. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

66.84M
Year ended 2025-12-31
+15.3%
3-year compound annual growth
+26.2%
5-year compound annual growth
2012-12-31: 13.07M2013-12-31: 16.98M2014-12-31: 19.07M2015-12-31: 26.45M2016-12-31: 30.28M2017-12-31: 481.7K2018-12-31: 2.33M2020-12-31: 20.88M2021-12-31: 39.03M2022-12-31: 43.60M2023-12-31: 44.68M2024-12-31: 47.65M2025-12-31: 66.84M66.84M
2012-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3166.84M+40.3%2026-02-24, From 2025-01-01
2024-12-3147.65M+6.7%2026-02-24, From 2024-01-01
2023-12-3144.68M+2.5%2025-02-27, From 2023-01-01
2022-12-3143.60M+11.7%2024-02-29, From 2022-01-01
2021-12-3139.03M+87.0%2023-03-02, From 2021-01-01
2020-12-3120.88Mn/a2022-02-24, From 2020-01-01
No annual figure between 2018-12-31 and 2020-12-31.
2018-12-312.33M+383.8%2019-03-06, From 2018-01-01
2017-12-31481.7Kn/c2019-03-06, From 2017-01-01
2016-12-3130.28M+14.5%2018-02-26, From 2016-01-01
2015-12-3126.45M+38.7%2017-03-15, From 2015-01-01
2014-12-3119.07M+12.3%2017-03-15, From 2014-01-01
2013-12-3116.98M+29.9%2016-03-10, From 2013-01-01
2012-12-3113.07Mn/a2015-03-12, From 2012-01-01